Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
71 Cards in this Set
- Front
- Back
What are the structure of aminoglycosides
|
six membered rings, with amino group, linked to 2 or more sugars
|
|
What is the name of the aminoglyocisde ring
|
aminocyclitol
|
|
What are the 3 main aminoglycoides
|
Tobramycin
Amikacin Gentamicin |
|
Are aminoglycodies bacterial or static
|
Bacertical
|
|
What is main MOA of aminoglycoides
|
distrupting protein synthesis by binding to the 30S ribosome
|
|
What 2 routes to aminoglyocisdes eneter the periplasmic space
|
Diffusion porin
phospholodi bilayer |
|
Once the drugs are in the periplasmic space, how are they transfer acroos the mebrane
|
ELECTRON TRANSPORT
NEED O2 |
|
So if aminoglycides require oxgen to pass the membrane, what baceria do they NOT treat
|
ANAEROBICS
|
|
Once aminoglycosides are INSIDE the bacteria, they bind
|
to the 30S riboones, and interfer with mRNA
|
|
Although most inhibitors of microbial protein synsther are bacteroSTATIC, aminoglycodies are bactericidal, what is other MOA
|
compete with Mg2 and Ca+ that link lipoplosaccarhisa, dn may result in holes in the cell well mebrane, resulting in holes in the cell membrane
|
|
What are the MAJOR mechanism of resistance with aminoglycosides
|
Target site modication (ribosmonal mutations RARE)
Enzyme inactivation---Aminoglyocisde modfiying enzymes Drug efflux (NOT_ Decreased drug penetration, into periplasmic space though alterion in porin |
|
WAmoinoglyocidies modiying enzymes, do what once aminglycosides are IN the periplasmic space
|
inactivation by phrophsorylation
|
|
Aminoglycosides modifiny enzymes inlcude phophorotransferase, andenyltransferase, and actelytranferase, each aminoglycodies is inactivated differently, and is it consider a class resistance
|
NO
|
|
Spectrum of activity of Aminoglycosides
|
Gram + aerobes (only in combination)
Gram - aerboes--including Pseudomas aerguinosa and Acinectorbacter ANANEROBES-no activity |
|
Spectrum of activity of Tobramycin and Gentamicin
|
Gentamicin--better Serraita
Tobramcin is better against P. aeruginosa |
|
Amikacin is POOR substrate for
|
amino-glycoside modfiying enzymes
|
|
Amikacin is BEST for
|
P. aeurginosa and acinteobacter---less maingolycisde modifying enzymes
|
|
What is the absoprtion of aminoglycosides
|
POOR only adminstered parentally
|
|
What is distriubtion of aminoglyosides
|
well--
|
|
What is CNS distribtion
|
POOR
|
|
What is elimination of aminoglycosides
|
KIDNEY
|
|
What are the 2 main toxicities with AMINOGLYCOSIDES
|
Neprhotoxicity
Ototoxocity |
|
Nephrotoxocity occur in 25% of pts, b/c amingolycosides are elminated via glomerular filtration, and at HIGH doses and LONG time period, the drug
|
accumated within proximal tuble and cause necrosis
|
|
What are the MAJOR risk factors for nephrotoxciithy
|
Dose, druation and underlaying renal disease
|
|
Ototoxcity is another MAJOR adverse effect of aminoglycosides, what tones are usually affect and what else
|
HIGH frequnecy tones, and also vestibular impairment
|
|
Nephotoxcit is usually reversible, what is otoxicity
|
result in PERMENANT loass
|
|
In animal modies risk for toxcities is greater for gentamicin>tobramycin>amkiacin, but most clincian FEEL
|
not enough evidence and suseptibily is MORE important
|
|
What is example of combinatio of aminglycosdie for severe GRAM + infections
|
endocarditis
|
|
Most of the resistance of Aminoglycosides are carried on
|
plasmids
|
|
What was the first identifed quinolones
|
Naldixic acid
|
|
The addition of the Fluorine to C6 position did what
|
increased biologocial activity, and floroquinoles were bone
|
|
Also addition of the piperrzinyl at C7 was imporatant, and what made CIPRO
|
also added cycloproyl group
|
|
CIPROFLOXACIN was an EARTH-shattering development, WHY
|
Braod spectum antibiotcis
GOOD ORAL vioability excellent tissue peentaion |
|
What are the MAINM 4 quinonles used today
|
Ciprofloxainc
Levofloxacin Monofloxacin Gemifloacin |
|
What are the 2 MAJOR sites of action for quinolones
|
Toposiomerase II (DNA gyrase)
Topsoirase IV |
|
Topisomerase II (DNA gryrase) consists of 2 subunits
|
GyrA and GyrB
|
|
Topisomerase IV consists Also OF 2 SUBUNITS,
|
ParC and Par E
|
|
The primary taget of DNA gyrase of Topoisomerase II is
|
Gram -
|
|
The primary target of Toposimerase IV is
|
Gram + bacterai
|
|
IN REALITY--inbhition of either results in SOME degree of activity against Gram + or -
|
YES
|
|
What is another MOA of Quinolones, which can result in
|
SOS response--explosion of cell
|
|
What is the MAJOR fxn of DNA gyrase in bacteria
|
negative supercoils in the DNA, allow for packing
|
|
GyrA is involved
|
breaking and uniting strands
|
|
GyrB is involved in
|
ATP and allow DNA strand passage
|
|
Quinolones interact MAINLY with DNA gyrase drug-enzyme complex, its primary binding site is
|
on GyrA
|
|
What do Quinolones PREVENT
|
resealing of nicked DNA, and results in cell death
|
|
What is the fnx Toposimerase IV
|
seprates daughter chromsoenes are DNA replication
|
|
Quinoles ineracts ALSO with Topoisomerase IV, and what site
|
ParC
COMPLES of enzyme-DNA-drug |
|
What is Quinoles prevent with TOPOISOMERASE IV,
|
releasing of the nicked DNA--
|
|
What are 2 MAJOR mechanism of resistance with Quinolones
|
Alteration is target site---muations in DNA gyrase and topisomerase IV
Drug efflux |
|
What is MAJOR mutation in gram - bacteria
|
gry A mutations
minor gyr B |
|
What is MAJOR mutation in gram +
|
ParC
minor mar E |
|
A single step mutation can lead to
|
low level resistance
|
|
Whereas a mutation in BOTH genes can lead to
|
clincally revelvant rsistance
|
|
What is the ORAL bioavialbity of Floroquinoles
|
EXCELLENT
|
|
Can you take fluoroquinoles with FOOD
|
yes--not affected
|
|
Florquinoes are well disribted, what is CNS penetration
|
POOR
|
|
Folorquinolones are ELMINATED, and expection
|
RENALLY,
except Moxifloxin---heaptiallyt clearn |
|
What is half-life of Fluoroquinolones
|
LONG---4-13 hours
allow qd dosing cipo BID |
|
What is spectrum of activity of Fluoroquinolones
|
Gram + aeroes
Gemi >Moxi >Levo >Cipro Gram - (All enterobacteriaceae, moraxella, Haemophilus, Neissera Anerobic acity, Moxi Atypicals--EXCELLENT |
|
Fluorquinoles have POOR activity against what Gram +
|
MRSA or enterococcus
|
|
What is the BEST class AND only for AYTYPCIALS
|
Fluroquionoles
|
|
What are the only 2 fluoroquinoles that treat Pseudmonas
|
Cipro and Levo
|
|
ALL things consider what are the SAFEST and best tolerated antiobotics
|
Fuloroquiones
|
|
Common SIDE effects of Fluoroquinolones inlcude
|
GI
CNS RASH |
|
Incidnce of RASH with fulorquinoes is NOT hypersenstive, is MORE commo nwith gemifloxacin, and what pts are at risk
|
women <40, and longer duration
|
|
What is the Black box warning with fluorquinoles
|
tendonitis and tendon rupture
|
|
Tendonits and Tendone ruputre is rare, occurs 1-2 weeks AFTER starting drug therapy, who are MOST at risk
|
>60 ages and taking corticosteriods
|
|
Fluoroquinolones are contraindicated in
|
pregnancy and children <16
|
|
What are the drug interactions with Fluoroquinolones (F+)
|
Anatacids--or any prodtions with cations
Ferrous sulfate Sulcralfate |
|
What is the only flurorquiones that inhibits CYP450, so interactions with warfarin and theophylline
|
cipro
|